BGMS director sells 22,251 at $6.224 and 25,000 at $5.132

Bio Green Med Solution (BGMS) filed a Form 4 reporting insider stock sales by Kua Khai Loon, a Director.

Rhea-AI Filing Summary

Bio Green Med Solution (BGMS) filed a Form 4 reporting insider stock sales by Kua Khai Loon, a Director. On 09/12/2025, the insider sold 22,251 shares of common stock at $6.224 per share, leaving 363,160 shares beneficially owned. On 09/16/2025, the insider sold an additional 25,000 shares at $5.132 per share, with 338,160 shares beneficially owned afterward. Both positions are listed as Direct (D) ownership.

Insider Trade Summary

Net Seller: 47,251 shares

Net Sell 2 txns

Insider Kua Khai Loon

Role 10% Owner

Sold 47,251 shs ($267K)

Type	Security	Shares	Price	Value
Sale	Common Stock	25,000	$5.132	$128K
Sale	Common Stock	22,251	$6.224	$138K

Holdings After Transaction: Common Stock — 338,160 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BGMS report on Form 4?

A Director, Kua Khai Loon, reported two sales of BGMS common stock on 09/12/2025 and 09/16/2025.

How many BGMS shares were sold and at what prices?

Sold 22,251 shares at $6.224 on 09/12/2025 and 25,000 shares at $5.132 on 09/16/2025.

How many BGMS shares did the insider hold after each sale?

After 09/12/2025: 363,160 shares. After 09/16/2025: 338,160 shares.

What is the ownership type reported for these BGMS holdings?

The holdings are reported as Direct (D) ownership.

What is the insider’s relationship to BGMS?

The reporting person is identified as a Director of BGMS.

Were any derivative securities reported?

No derivative securities were listed in the provided Table II excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/10/2025 - 06:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kua Khai Loon

(Last) (First) (Middle)

NO 28 JALAN EKOFLORA 1/13 TAMAN EKOFLORA

(Street)

JOHOR BAHRU N8 81100

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bio Green Med Solution, Inc. [ BGMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/12/2025		S		22,251	D	$6.224	363,160	D
Common Stock	09/16/2025		S		25,000	D	$5.132	338,160	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Kua Khai Loon	10/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.